Schlieren, Switzerland

Diana Darowski

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Diana Darowski

Introduction

Diana Darowski, an accomplished inventor based in Schlieren, Switzerland, has made significant contributions to the field of biotechnology with her innovative inventions. With three patents to her name, Diana focuses on the development of advanced assays that utilize chimeric antigen receptor (CAR) technology to enhance specificity testing for antigen binding moieties.

Latest Patents

Diana's latest patents include:

1. **Universal reporter cell assay for specificity test of novel antigen binding moieties** – This invention relates to specificity assays using cell cultures, particularly focusing on CAR-T cell assays that test novel antigen binding moieties. It features a method for using CAR-T cells, which are transfected or transduced with an engineered chimeric antigen receptor, to specifically bind to recognition domains of antigen binding molecules. The invention encompasses methods and kits designed for the specificity testing of candidate antigen binding moieties and nucleic acid molecules.

2. **CAR-T cell assay for specificity test of novel antigen binding moieties** – Similar in essence to her first patent, this invention underscores the application of CAR-T cells to assess antigen binding moieties across different formats. The technology revolves around the use of engineered CARs that can bind specifically to target antigens, such as tumor-associated antigens.

Career Highlights

Diana's innovative mindset and dedication have led her to work with Hoffmann-La Roche Inc., one of the leading pharmaceutical companies in the world. Her role there positions her at the forefront of biotechnological advancements, where she continues to contribute to the development of cutting-edge diagnostic and therapeutic solutions.

Collaborations

In her endeavors, Diana works alongside Christian Klein, a respected colleague, to propel their research forward. Their collaboration has proved fruitful, enabling them to combine their expertise and push the boundaries of what's possible in the field of antigen binding studies.

Conclusion

Diana Darowski exemplifies the spirit of innovation in the biotechnology sector. With her groundbreaking patents and cooperative efforts at Hoffmann-La Roche Inc., she plays a pivotal role in enhancing the specificity testing capabilities for novel antigen binding moieties. Her work not only advances scientific understanding but also has the potential to impact the development of therapeutic interventions in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…